Previous 10 | Next 10 |
Completed Transformative Year with Q4 2020 Revenue Up 10% Year-Over-Year, Full Year 2020 Revenue up 14% Well Positioned for Growth in 2021 BEDFORD, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation comp...
BEDFORD, Mass., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care, today announced that the Company plans to issue its fourth quarter and ...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Anika Therapeutics, Inc. 2020 Q3 - Results - Earnings Call Presentation
Anika Therapeutics, Inc. (ANIK) Q3 2020 Earnings Conference Call November 04, 2020, 05:00 PM ET Company Participants Kristen Galfetti - IR Cheryl Blanchard - President and CEO Michael Levitz - EVP, CFO and Treasurer Conference Call Participants Jim Sidoti - Sidoti Mike Petusky - Barrington Re...
Image source: The Motley Fool. Anika Therapeutics Inc (NASDAQ: ANIK) Q3 2020 Earnings Call Nov 4, 2020 , 5:00 p.m. ET Operator Continue reading For further details see: Anika Therapeutics Inc (ANIK) Q3 2020 Earnings Call Transcript
Anika Therapeutics, Inc. (ANIK) Q3 2020 Earnings Conference Call October 4, 2020 4:50 PM ET Company Participants Kristen Galfetti - Investor Relations Cheryl Blanchard - President and Chief Executive Officer Mike Levitz - Executive Vice President, Chief Financial Officer and Treasurer Confere...
Anika Therapeutics (ANIK): Q3 Non-GAAP EPS of $0.05 beats by $0.06; GAAP EPS of -$0.45 misses by $0.44.Revenue of $31.7M (+6.7% Y/Y) beats by $1.59M.Press Release For further details see: Anika Therapeutics EPS beats by $0.06, beats on revenue
Revenue Increased 7% Year-over-Year to $ 31.7 Million Repaid $25 M illion of Outstanding Credit Facility Continued Expansion of Joint Preservation Product Portfolio BEDFORD, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Anika ...
BEDFORD, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care, today announced that the Company plans to issue its third quarter 2020 ...
The FDA grants 510(k) clearance to Anika Therapeutics' (ANIK) WristMotion Total Arthroplasty System for the replacement of the wrist joint due to rheumatoid arthritis, osteoarthritis, or post-traumatic arthritis.The event triggers a $5M milestone payment to former equity holders of Arthrosurf...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...